###begin article-title 0
Expression of C-terminal deleted p53 isoforms in neuroblastoma
###end article-title 0
###begin p 1
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 109 125 109 125 <email xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emay@vjf.cnrs.fr</email>
*Correspondence may also be addressed to Evelyne May. Tel: +33 1 49 58 33 50; Fax: +33 1 49 58 33 68; Email: emay@vjf.cnrs.fr
###end p 1
###begin p 2
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
###end p 2
###begin p 3
GenBank accession nos KO3199 (mRNA) and X54156 (HSP53G)
###end p 3
###begin p 4
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 4
###begin p 5
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 798 803 795 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 926 935 923 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Genes Dev</italic>
###xml 938 940 935 937 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">19</bold>
###xml 1077 1082 <span type="species:ncbi:9606">human</span>
The tumor suppressor gene, p53, is rarely mutated in neuroblastomas (NB) at the time of diagnosis, but its dysfunction could result from a nonfunctional conformation or cytoplasmic sequestration of the wild-type p53 protein. However, p53 mutation, when it occurs, is found in NB tumors with drug resistance acquired over the course of chemotherapy. As yet, no study has been devoted to the function of the specific p53 mutants identified in NB cells. This study includes characterization and functional analysis of p53 expressed in eight cell lines: three wild-type cell lines and five cell lines harboring mutations. We identified two transcription-inactive p53 variants truncated in the C-terminus, one of which corresponded to the p53beta isoform recently identified in normal tissue by Bourdon et al. [J. C. Bourdon, K. Fernandes, F. Murray-Zmijewski, G. Liu, A. Diot, D. P. Xirodimas, M. K. Saville and D. P. Lane (2005) Genes Dev., 19, 2122-2137]. Our results show, for the first time, that the p53beta isoform is the only p53 species to be endogenously expressed in the human NB cell line SK-N-AS, suggesting that the C-terminus truncated p53 isoforms may play an important role in NB tumor development.
###end p 5
###begin title 6
INTRODUCTION
###end title 6
###begin p 7
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 227 228 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 680 681 680 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 682 683 682 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 863 864 863 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 1181 1182 1181 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 1314 1315 1314 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 373 378 <span type="species:ncbi:9606">human</span>
###xml 465 470 <span type="species:ncbi:9606">human</span>
The p53 tumor suppressor gene remains the most frequently altered gene in human tumors. Several p53 mutation databases have been reported previously (1-3), and to date, more than 1500 different p53 mutants have been described (4). Functional inactivation of p53 is usually due to gene mutation, deletion or protein degradation. In general, the majority of p53 mutations in human neoplasia are missense mutations affecting the DNA-binding domain (DBD). Unlike other human cancers, p53 in neuroblastoma (NB) is rarely mutated in the primary tumor at diagnosis but high levels of wild-type p53 (wt p53) protein expression have been found in the cytoplasm of undifferentiated tumors (5,6). More recently, in normal unstressed cells, wt p53 protein was found to be retained in the cytoplasm as a latent form, in huge, p53-associated protein complexes known as 'Parc' (7). The steady-state concentration of p53 in normal unstressed cells is usually very low because of the short half-life of the wild-type (wt) protein. Overexpression of p53 in most of the transformed cells containing a missense mutation within the p53 gene appears to be due to the increased stability of mutated p53 (8). In unstressed NB cells, high wt p53 expression may reflect the embryonic origin of NBs, in which precursor cells fail to mature (9).
###end p 7
###begin p 8
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 827 828 827 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 1117 1119 1117 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 1342 1344 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 193 200 <span type="species:ncbi:9606">patient</span>
###xml 354 361 <span type="species:ncbi:9606">patient</span>
###xml 1034 1041 <span type="species:ncbi:9606">patient</span>
p53 mutations are unusual in human NB but, when they do occur, are found in post-chemotherapy tumors. In this respect, Tweddle et al. (10) described how two NB cell lines derived from the same patient can elicit a different p53 status: wt p53 for SK-N-BE(1a) established before treatment, and mutated p53 for SK-N-BE(2c) established after relapse of the patient under treatment with cytotoxic agents such as cyclophosphamide, doxorubicin, vincristine and radiotherapy. In NB cell lines, p53 mutation has been found in multidrug-resistant cells (11). Various types of p53 mutation have been detected in NB cells and can lead to inactivation either by shut-down of protein expression or production of aberrant p53 products. Indeed, in LAN-1 cells, p53 nonsense mutation at cysteine 182 in exon 5 leads to the absence of protein (9), whereas in SK-N-BE(2) cells, missense mutation at codon 135 (C135F) leads to stable overexpressed protein (11). By analyzing IGR-N-91, a cell line established in our laboratory from the bone marrow of a patient with metastatic NB after unsuccessful Adriamycin-vincristine chemotherapy (12), we identified another type of aberrant protein that arises from the duplication of exons 7-8-9. This duplication spans from amino acids 225 to 331, which represent part of the DBD and part of the oligomerization domain (13). However, each p53 mutant has been described in the literature as a case report, and so far, no comparative study has been undertaken to link their biochemical features with functional properties.
###end p 8
###begin p 9
###xml 697 705 697 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21/WAF1</italic>
###xml 732 736 732 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BAX,</italic>
###xml 804 812 804 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21/WAF1</italic>
###xml 98 103 <span type="species:ncbi:9606">human</span>
###xml 232 237 <span type="species:ncbi:9606">human</span>
###xml 564 569 <span type="species:ncbi:4932">yeast</span>
In the present study we report two novel p53 C-terminus mutants identified in SK-N-AS and IGR-NB8 human NB cell lines. The biological properties of these two new variants were analyzed in comparison with p53 isolated from six other human NB lines: three [LAN-1, SK-N-BE(2) and IGR-N-91] expressing mutant p53 and three (SH-SY5Y, LAN-5 and IMR-32) expressing the wt protein. This characterization was done by using a range of functional assays: (i) the ability of the protein to bind with p53 consensus sequence using the functional analysis of separated allele in yeast (FASAY); (ii) the ability of the protein to transactivate the p53-responsive element (RE) identified either in the promoter of p21/WAF1 or in the first intron of BAX, using luciferase reporter assay; (iii) the induction of endogenous p21/WAF1 gene expression under stress conditions.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
Neuroblastoma cell lines, culture and drug treatments
###end title 11
###begin p 12
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 692 693 692 693 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 162 167 <span type="species:ncbi:9606">human</span>
###xml 447 452 <span type="species:ncbi:9606">human</span>
###xml 532 539 <span type="species:ncbi:9606">patient</span>
###xml 718 722 <span type="species:ncbi:9913">calf</span>
The parental human NB SH-SY5Y, SK-N-AS, IMR-32 and SK-N-BE(2) cell lines were purchased from the European Collection of Cell Cultures (ECACC, Wiltshire, UK). The human IGR-NB8 cells (a gift of Prof. Gilles Vassal, UPRES EA 3535, Institut Gustave Roussy, Villejuif) were derived from a previously untreated localized NB (14). The LAN-1 and LAN-5 cell lines were provided by Dr Nicole Gross (Pediatric Oncology Research, Lausanne, Switzerland). The human IGR-N-91 cell line was established in our laboratory from the bone marrow of a patient with metastatic NB after unsuccessful adriamycin-vincristin chemotherapy (12). LAN-1, LAN-5 and IMR-32 were grown in RPMI medium supplemented with 2 mM l-glutamine and 10% fetal calf serum and gentamicine 10 mug/ml. Others cell lines were cultured in DMEM.
###end p 12
###begin p 13
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
For activation of endogenous p53, cells were treated with cis-platinum (Sigma) (10 mug/ml) for 24 h then lysed for western blot analysis.
###end p 13
###begin title 14
Western blot analysis
###end title 14
###begin p 15
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 390 394 389 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DAKO</italic>
This procedure was carried out as described previously (13). Protein lysates (50 mug) were submitted to 10% SDS-PAGE, and then transferred onto nitrocellulose filters. After saturation, the membranes were incubated with primary antibody diluted in 0.1% phosphate-buffered saline, Tween-20 and 3% skim milk. The primary antibodies used were anti-p53 monoclonal antibody (clone DO-7, 1/1000, DAKO), anti-p21/WAF1 monoclonal antibody (Ab-1, 1/200, Oncogene Research) and anti-beta-actin monoclonal antibody (1/1000; Chemicon) as internal control. Protein bands were detected by ECL system (Amersham).
###end p 15
###begin title 16
PCR, plasmids cloning
###end title 16
###begin p 17
###xml 523 525 511 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sub>
###xml 789 796 777 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1062 1063 1050 1051 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</bold>
###xml 1091 1097 1079 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1099 1101 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 1149 1152 1137 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pfu</italic>
Genomic DNA was extracted using lysis buffer containing 20 mM Tris-HCl, pH 7.5; 0.4 M NaCl; 0.5% SDS; 10 mM EDTA, treated with proteinase K (200 mug/mul), purified with phenol/chloroform, precipitated with ethanol and dissolved in DNase free water. Total RNA were purified using RNAble reagent (Eurobio), precipitated with isopropanol and dissolved in RNase free water. cDNA was obtained by reverse transcription of 1 mug of total RNA using Superscript IItrade mark RNase H-Reverse transcriptase (Invitrogen) and Oligo-d(T)16 in conditions specified by the manufacturer. Amplification of full-length p53 coding region from SH-SY5Y, IGR-N-91, IGR-NB8 and SK-N-BE(2) cell lines was performed using forward primer at position 152 and reverse primer at position 1583 (F1 and R7, respectively, Table 1; GenBank accession no. K03199). p53 cDNA from SK-N-AS cells for cloning was obtained from RT-PCR using F1 and reverse primer i9+: 5'-GCAAAGTCATAGAACCATTTTCAT-3' (nucleotide position 14989, GenBank accession no. X54156) primers which encompass from exon 1 to exon i9+ first identified by Flaman et al. (15) included. The PCR was done in the presence of pfu Hotstart DNA polymerase (Stratagene) for 30 cycles of 1 min at 90degreesC, 1 min at 65degreesC and 2 min 30 s at 72degreesC using PTC-100 thermocycler (MJ-Research).
###end p 17
###begin p 18
The p53 cDNA from SH-SY5Y, SK-N-AS, IGR-N-91, IGR-NB8 and SK-N-AS cells were then cloned into pcDNA3.1/V5-His-Topo vector (Invitrogen) according to the manufacturer's instruction. The p53 sequence of each cell line was investigated by sequencing of plasmids after cloning. Sequencing was performed by Genome Express (Meylan, France).
###end p 18
###begin p 19
###xml 162 170 162 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21/WAF1</italic>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BAX</italic>
###xml 277 280 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BAX</italic>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 489 492 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BAX</italic>
The pDDm-TO harboring p53 dominant negative form (p53DD) pGL3-E1bTATA and the pE1B-hWAF1 firefly luciferase reporter containing the p53-responsive element of the p21/WAF1 promoter were described previously (16,17) pE1B-BAXi contains the p53RE identified in the intron 1 of the BAX gene [(18) and D. Munsch, personal communication]. Oligonucleotides TCGAGGGCAGGCCCGGGCTTGTCG and CTAGCGACAAGCCCGGGCCTGCCC were annealed and cloned into pGL3-E1bTATA digested with NheI and XhoI to obtain pE1B-BAXi. The pcDNA3-DeltaNp73alpha expression plasmid was a gift of Dr Daniel Caput (SANOFI, Labeges, France).
###end p 19
###begin title 20
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
Fluorescent in situ hybridization (FISH)
###end title 20
###begin title 21
Cytogenetic preparations
###end title 21
###begin p 22
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 31 36 <span type="species:ncbi:9606">human</span>
Metaphase spreads from healthy human male lymphocytes and tumor cell lines were prepared as described previously (19). BAC probe RP11-199F11, containing a 167 kb region spanning TP53 gene, was labeled by random priming in the presence of Alexa 594-dUTP (Molecular Probes). A commercial probe specific for chromosome 17 centromere, and labeled with spectrum green, was obtained from Vysis. After over-night cohybridization of the probes in the presence of Cot-1 DNA, the slides were washed and DNA counterstained with DAPI. The preparations were observed with an epifluorescence microscope and images captured with a Vysis imaging station. Between 3 and 14 metaphases spreads and 30-200 nuclei were examined for each cell line.
###end p 22
###begin title 23
Luciferase reporter assays
###end title 23
###begin p 24
###xml 90 91 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
LAN-1 or SH-SY5Y cells were seeded in duplicates onto 6-well plates at a density of 2 x 104 cells per cm2 and cotransfected 24 h later with 0.5 mug (2.5 mug/ml) of pGL3 firefly luciferase reporter gene plasmid under the control of either pE1B-hWAF1 or pE1B-BAX using lipofectamine 2000 and 1 mug of either a p53 expressing plasmid or an empty vector. At 24 h after transfection, cells were lysed with 200 mul/well of passive lysis buffer provided with the 'Luciferase assay kit' (Promega). Luciferase activity was measured using Microlumat LB96P luminometer (EG & G Berthold Instrument).
###end p 24
###begin title 25
###xml 20 25 <span type="species:ncbi:4932">yeast</span>
Functional assay in yeast
###end title 25
###begin p 26
###xml 426 430 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADE2</italic>
###xml 498 500 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 576 580 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADE2</italic>
###xml 722 726 712 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADE2</italic>
###xml 261 266 <span type="species:ncbi:4932">yeast</span>
cDNA was obtained by RT of 1 mug of total RNA using Superscript IItrade mark RNase H-Reverse transcriptase (Invitrogen) and random hexamers to prime the synthesis in conditions specified by the manufacturer. p53 cDNA was amplified by PCR and cotransformed into yeast, IG397 Ade2 strain, together with either pRDI-22 vector for p53-standard assay or pFW35 and pFW34 plasmid for 5' or 3' split assay, respectively, carrying the ADE2 open reading frame under the control of a p53-responsive promoter (20). In a selective medium lacking leucine, wt-p53 activates transcription of ADE2 gene that encodes enzyme-phosphoribosylimidazole carboxylase-implicated in adenine biosynthesis. Therefore, a colony of cells that expresses ADE2 gene is white whereas the one composed of cells where ADE2 gene is not expressed owing p53 mutation is red.
###end p 26
###begin title 27
RESULTS
###end title 27
###begin title 28
P53 status in SK-N-AS and IGR-NB8 cells
###end title 28
###begin p 29
###xml 335 344 334 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 450 452 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 453 455 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 666 667 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 784 786 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 863 865 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
We first compared the migration profiles of p53 expressed in SK-N-AS and IGR-NB8 with those expressed in the other six NB cells, SH-SY5Y, LAN-5, LAN-1, IMR-32, SK-N-BE(2) and IGR-N-91. Western blots from 50 mug of total protein extracts were revealed with p53 monoclonal antibody (DO-7). A range of profiles was identified as shown in Figure 1A. As expected, p53 extracted from the three cell lines, SH-SY5Y, LAN-5 and IMR-32, expressing wt protein (13,21) migrated at the wt position. Of particular note in these three wt p53 cell lines was an additional faint band that migrated faster than the full-length protein. The LAN-1 cells were found to be p53 deficient (9). The SK-N-BE(2) cell line showed an intense band reflecting p53 stability due to a missense mutation at codon 135 (11). As expected, due to the previously identified duplication of exons 7-8-9 (13), p53 protein migration was delayed in the IGR-N-91 cells. In contrast, the p53 protein in the SK-N-AS cell line migrated noticeably faster than the wt protein, indicating that it was smaller in size. The p53 protein in the IGR-NB8 cell line was even smaller than that in SK-N-AS.
###end p 29
###begin p 30
###xml 113 120 113 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 125 134 125 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
###xml 392 401 392 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 790 791 790 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 892 901 892 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
To analyze the coding region of each of the p53 variants, RT-PCR was performed using p53-specific F1-R7 primers (Table 1 and Figure 1B). The expected 1430 bp for full-length p53 was amplified from wt p53-expressing SH-SY5Y, LAN-5 and IMR-32 cell lines. As SK-N-BE(2) harbors a single point mutation at codon 135 (C135F), the amplified fragment analyzed by electrophoresis migrated as wt p53 (Figure 1B). The longer RT-PCR fragment from the mutated IGR-N-91 cell line resulted from the duplication of exons 7-8-9, as shown in our previous data (13), which corresponds to extra nucleic material of 321 nt. For the LAN-1 cells, no amplified fragment was observed in accordance with published data, which demonstrates the extremely low levels of p53 mRNA and the undetectable level of protein (9). An amplified fragment of the same length as the wt protein was observed in the IGR-NB8 cell line (Figure 1B). Indeed, complete gene sequencing revealed a point mutation E326STOP leading to a truncated protein at C-terminus. No fragment, however, was amplified from SK-N-AS with F1-R7 primers.
###end p 30
###begin p 31
###xml 427 434 427 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 468 477 468 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
To further map the p53 mRNA transcribed in these cells, series of RT-PCR tests were performed using the forward primer, F2 (exon 8 position 1008th according to GenBank accession no. K03199), matched with different reverse primers, R3 (at the junction of exon 8/9, nt position 1124), R4, R5 (in exon 9 at positions 1154 and 1184, respectively), and R6 (in exon 10, at position 1230). The sequences of these primers are given in Table 1 and the results are presented in Figure 2A. SK-N-AS cDNA gave an amplified fragment of the same size as SH-SY5Y cDNA with the three primer pairs, F2/R3, F2/R4 and F3/R5. However, in contrast to SH-SY5Y, no fragment was obtained with SK-N-AS cDNA using the F2/R6 primer pair, which suggests the absence of exon 10 in SK-N-AS mRNA.
###end p 31
###begin title 32
The p53 protein expressed in SK-N-AS is the p53beta isoform
###end title 32
###begin p 33
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 332 337 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 353 355 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 865 872 853 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 899 908 887 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 1394 1403 1376 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 129 134 <span type="species:ncbi:9606">human</span>
An alternatively spliced form of human p53 mRNA with an additional 133 bp exon derived from intron 9 has been detected in normal human lymphocytes (15). This spliced variant named 'i9+' encodes a truncated protein of 341 amino acids including 10 new amino acids derived from the novel exon, the p53beta isoform according to Bourdon et al. nomenclature (22). This led us to hypothesize that the shorter protein expressed by the SK-N-AS cell line could be the p53beta isoform. To test this hypothesis, RT-PCRs were performed using primer sets designed to amplify the 3' region of p53 mRNA encoding either the specific C-terminal part of the wt protein (wt C-ter) or the specific C-terminal part of the beta isoform (beta C-ter). In parallel amplification with a primer pair amplifying the DBD was used as control. The sequences of these oligonucleotides are given in Table 1. The results presented in Figure 2B are consistent with the only expression of the p53beta isoform in SK-N-AS as no band was observed in lane using specific C-ter primer located in exon 10. Interestingly, RT-PCR using SH-SY5Y (SH) gave an amplified fragment not only with the primer pair specific to the C-ter domain of wt p53 but also with the primer pair specific to the p53beta isoform. This result, combined with the presence of an additional faint band migrating faster than wt p53 in denaturing polyacrylamide gel (Figure 1A), strongly suggests that both the p53 full-length protein and the beta isoform were expressed in the SH-SY5Y cells.
###end p 33
###begin p 34
###xml 135 142 135 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 387 392 387 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 457 462 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 465 467 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
The full-length SK-N-AS p53 cDNA was then amplified with the forward primer F1 and a reverse primer located within the novel exon i9+ (Table 1). This amplified fragment was cloned in pcDNA3/V5-His-Topo, as described in Materials and Methods. Its sequence analysis confirmed that the truncated p53 expressed in SK-N-AS was encoded by the i9+ splice variant described previously by Flaman et al. (15) that encodes the p53beta isoform characterized by Bourdon et al. (22).
###end p 34
###begin p 35
###xml 208 215 208 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 341 349 341 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
###xml 698 701 698 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
A series of genomic amplifications were performed to identify a possible deletion within the intron 9 that could account for the absence of normal size p53 in SK-N-AS cells. The primer sequences are given in Table 1. Amplifications were performed in parallel with total DNA extracted from SH-SY5Y and SK-N-AS cells. Results are presented in Figure 3. Normal size fragments that encompass the acceptor site of intron 9 were amplified with SH-SY5Y as well as with SK-N-AS DNA. On the contrary amplification fragments that encompass the intron 9 donor site were obtained only with SH-SY5Y but not with SK-N-AS DNA. These results identify a deletion of the intron 9/exon 10 junction within the SK-N-AS p53 gene.
###end p 35
###begin title 36
###xml 2 7 <span type="species:ncbi:4932">yeast</span>
A yeast functional assay confirmed the absence of p53 full-length expression in SK-N-AS and IGR-NB8
###end title 36
###begin p 37
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 199 203 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADE2</italic>
###xml 237 246 237 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 266 275 266 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADE2</italic>
###xml 364 373 364 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 389 398 389 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 483 492 483 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 517 524 517 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 796 803 784 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 53 58 <span type="species:ncbi:4932">yeast</span>
It is possible to detect p53 mutation using a simple yeast colony color assay as described by Flaman et al. (23). When the strain is transformed with a plasmid-encoding wt p53, the cells express the ADE2 gene and produce white colonies (Figure 4A, a, b2 and c1, and Figure 4B, dish a). Cells containing mutant p53 fail to express ADE2 and form small red colonies (Figure 4A, b and b1, and Figure 4B, dish c). When the p53 cDNA fragment is deleted, cells are unable to form a colony (Figure 4A, c and c2). As shown in Table 2, FASAY was performed as a p53-standard test with full-length cDNA or with the split version at the 5' and 3' end (15). The background of FASAY experiments is around 10%. p53 wt expressing SH-SY5Y and LAN-5, 2 wt cell lines, yielded approximately92-97% of white colonies (Table 2).
###end p 37
###begin p 38
###xml 294 301 294 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 306 315 306 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 394 403 394 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 552 559 552 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 994 1003 994 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 1213 1220 1213 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 953 958 <span type="species:ncbi:4932">yeast</span>
One hundred percent of the colonies carrying SK-N-BE(2) p53, which is homozygous for the C135F mutation, turned red with the standard or 5' split assay, whereas 94% of the colonies turned white with the 3' split assay since the missense mutation does not extend to the C'-terminus of the gene (Table 2 and Figure 4B, dish c). No colonies were observed with p53-deficient LAN-1 cells, (see also Figure 4A, c and c2). With SK-N-AS cells, the split 5' assay gave 96% white colonies, while the p53-standard and split 3' assay did not produce any colonies (Table 2). This means that the 5' terminus was intact whereas the 3' terminus had been deleted, as was confirmed by nucleotide sequence analysis. The IGR-NB8 colonies, however, were red both with the p53-standard assay and the split 3' assay. In the IGR-N-91 cell line, where p53 harbors two contiguous sets of exons 7-9, spanning the DBD and oligomerization domain, it is interesting to note that the yeast colonies were predominantly white (Figure 4B, dish b) with the split 5' and the split 3' assay (96 and 87% of white colonies, respectively) This suggests that the cells express a binding ability that is specific to wild-type p53 rather than mutated p53 (Table 2).
###end p 38
###begin title 39
Transcription activity of SH-SY5Y, IGR-N-91, SK-N-BE(2), SK-N-AS and IGR-NB8 p53 variants in mammalian cells
###end title 39
###begin p 40
###xml 153 161 153 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21/WAF1</italic>
###xml 210 213 210 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BAX</italic>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 846 854 846 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21/WAF1</italic>
###xml 858 861 858 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BAX</italic>
###xml 869 877 869 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 147 152 <span type="species:ncbi:9606">human</span>
###xml 194 199 <span type="species:ncbi:10090">mouse</span>
###xml 204 209 <span type="species:ncbi:9606">human</span>
To determine the transactivation ability of p53 variants in mammalian cells, we used a reporter gene strategy. The p53RE located within either the human p21/WAF1 promoter or the intron 1 of the mouse and human BAX gene [(18) and D. Munsch, personnal communication) were cloned in a luciferase reporter gene plasmid upstream of the E1B minimal promoter as described in Materials and Methods. The p53-negative LAN-1 cells were cotransfected with the p53 vectors expressing the p53 cloned from either SH-SY5Y, IGR-N-91, SK-N-BE(2), SK-N-AS or IGR-NB8 and the luciferase reporter plasmids. Both p53RE were strongly stimulated in cells cotransfected with wt p53 cloned from SH-SY5Y, as compared to cells cotransfected with an empty plasmid. In contrast, none of the p53 variants was able to transactivate the expression of luciferase driven by either p21/WAF1 or BAX p53RE (Figure 5).
###end p 40
###begin p 41
###xml 150 158 150 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21/Waf1</italic>
###xml 221 229 221 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
To test transactivation capability at the protein level, each variant was transfected into p53-negative LAN-1 cells and the stimulation of endogenous p21/Waf1 gene expression was analyzed by western blotting. As shown in Figure 6, in contrast to wt p53, none of the p53 variants was able to induce p21 protein accumulation.
###end p 41
###begin p 42
###xml 238 246 238 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21/Waf1</italic>
###xml 250 259 250 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BAX p53RE</italic>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 788 796 788 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 1064 1067 1064 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BAX</italic>
###xml 1072 1080 1072 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21/WAF1</italic>
###xml 1159 1162 1156 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BAX</italic>
###xml 1245 1250 1239 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1253 1255 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
We then tested for a possible dominant negative effect of these various mutants on wt p53-dependent transcriptional activity. To this end, SH-SY5Y cells were cotransfected with constructs encoding the luciferase gene driven by either the p21/Waf1 or BAX p53RE and the constructs expressing the various p53s cloned from IGR-NB8, SK-N-BE(2), IGR-N-91, SK-N-AS and IGR-NB8 NB cells or p53DD, a dominant negative mutant of wt p53 (24). The stress induced by transfection activated the transcriptional activity of the wt p53 expressed in SH-SY5Y, leading to a p53-dependent expression of luciferase as illustrated by the fact that coexpression of p53DD led to a substantial decrease in luciferase activity when compared to the luciferase activity of cells cotransfected with an empty plasmid (Figure 5). Compared to p53DD, mutants within the DBD isolated from IGR-N-91 or SK-N-BE(2) had only a moderate dominant negative effect on endogenous wt p53 transcriptional activity. More surprisingly, the transfection of the C-terminal truncated variant IGR-NB8 enhanced both BAX and p21/WAF1 p53RE activity. The coexpression of p53beta cloned from SK-N-AS also enhanced BAX p53RE activity. A similar effect has been reported already for p53beta by Bourdon et al. (22).
###end p 42
###begin p 43
When combined, these results show that all the p53 variants isolated from the NB cells had lost the ability to specifically transactivate the p53 target genes. Their effect on the transcriptional activity of endogenous wt p53 expressed in SH-SY5Y cells, however, largely depended on the p53 domain affected by the modification.
###end p 43
###begin title 44
All the identified p53 variants inhibited the induction of endogenous p21/WAF1 gene expression under stress conditions
###end title 44
###begin p 45
###xml 163 171 163 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21/WAF1</italic>
###xml 474 482 474 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7</xref>
We further examined whether the four p53 variants, SK-N-BE(2), IGR-N-91, SK-N-AS and IGR-NB8, had loss their ability to stimulate the endogenous expression of the p21/WAF1 gene, the archetypical cell cycle inhibitor and the true target of p53. To this end, cellular response to genotoxic stress was analyzed by western blot following treatment of the various cell lines with cisplatin, one of the most potent antitumor agents used in neuroblastoma. Results are presented in Figure 7. None of the mutant cells, regardless of the type of mutation, was able to induce p21/WAF1 protein accumulation, unlike the 3 p53 wild-type cells (SH-SY5Y, IMR-32 and LAN-5).
###end p 45
###begin title 46
Genomic status of TP53 region in the various cell lines
###end title 46
###begin p 47
###xml 446 449 446 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 647 650 647 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 798 806 798 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8</xref>
###xml 811 818 811 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 1122 1124 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 1246 1254 1246 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8</xref>
###xml 1259 1266 1259 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 1269 1272 1269 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1636 1643 1636 1643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 1669 1672 1669 1672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1988 1991 1988 1991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 2189 2192 2189 2192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 2415 2418 2415 2418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 2481 2489 2481 2489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 2641 2644 2641 2644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
According to Knudson's 'two hit' model of tumor suppressor gene functional inactivation, the mutation of one allele is supposed to be associated with a deletion of the second allele. To assess this genetic mechanism, we performed FISH experiments to search for deletions of one copy of the TP53 region, especially in cell lines with a mutated TP53 gene. For this purpose, metaphase preparations of the studied cell lines were cohybridized with a p53 DNA probe labeled in red (BAC clone RP11-199F11) as described previously (25) and a chromosome 17-specific centromeric probe labeled in green. The three cell lines shown previously to express a wt p53 protein (LAN5, IMR32 and SH-SY5Y), displayed as expected two signals with each probe, confirming the presence of both TP53 alleles in these cells (Figure 8 and Table 3). Conversely, IGR-N-91 and SK-N-AS cell lines displayed only one fluorescent signal for each probe, suggesting a whole chromosome 17 lost, or at least losses of the 17p arm and the centromeric region. The SK-N-BE(2) cell line has been described as containing only one chromosome 17 and one TP53 signal (10). In our analysis, only 10% of the cells displayed this characteristic, whilst most of the cells had two copies of both (Figure 8 and Table 3). p53 sequencing, however, confirmed the previously described mutation, and the absence of a normal allele, suggesting that the cells used in our study had acquired, during culture, an uniparental disomy for the TP53-mutated chromosome 17. Finally, the other two cell lines (LAN-1 and IGR-NB8) displayed highly variable genetic heterogeneity from one cell to the next (Table 3). Surprisingly, although p53 transcripts are extremely faintly expressed in LAN-1 cell line, all cells showed several FISH signals with the 167 kb BAC probe used here. To understand this apparent contradiction, an array-CGH experiment was performed on an oligo-array Agilent, which indicated a 133 kb interstitial deletion corresponding to the p53 coding region and the 97 kb upstream region. Accordingly, the fluorescent spots observed in FISH experiments on LAN-1 cells should be related to the hybridization of the 57 kb region downstream of p53 gene present in the BAC probe. IGRN-B8 cell line displayed a number of signals of both colors ranging from 0 to 4, with 87% of cells displaying a loss for one TP53 allele. Despite this genomic variability, analysis of the p53 protein showed a single shortened form in IGR-N-B8 cell line (Figure 1). Consequently, and as suggested for SK-N-BE(2) cell line, IGR-N-B8 cell line should contain a variable number of copies of chromosome 17 with mutated p53.
###end p 47
###begin title 48
DISCUSSION
###end title 48
###begin p 49
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 446 449 446 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 163 168 <span type="species:ncbi:9606">human</span>
The p53 gene, the 'genome guardian', is mutated in over 50% of human cancers, with the most common mutations being missense mutations (>2/3 of mutations) (26). In human neuroblastoma tumors, p53 mutations are rarely present at the time of diagnosis (5,27); however, oncogenic p53 mutations can be found in advanced neuroblastomas that often relapse following high-dose chemotherapy (10). In contrast, in breast cancers, it has been reported that p53 mutations might improve response to high-dose chemotherapy including therapy with epirubicin and cyclophosphamide (28).
###end p 49
###begin p 50
###xml 204 212 204 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig9">Figure 9</xref>
###xml 264 267 264 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 600 605 600 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 832 834 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 884 890 877 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 892 894 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 1466 1475 1450 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 1687 1689 1671 1673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1836 1838 1820 1822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 1867 1869 1851 1853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 2355 2356 2337 2338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 68 73 <span type="species:ncbi:9606">human</span>
An investigation into the p53 genomic status and functions of eight human NB lines revealed that all five of the mutated cell lines had distinct genetic characteristics as is schematically represented in Figure 9: SK-N-BE(2) with a single missense mutation in the p53 gene, encoding a highly stable full-length protein. SK-N-AS and IGR-NB8 proteins, although they have intact transactivation and DBDs, were truncated at the C-terminus generating 341 and 326 amino acids respectively; they therefore lack the tetramerization domain that is essential for an active conformation. Very recently, Bourdon et al. (22) reported the putative occurrence of beta and gamma isoforms from different tissues due to alternate splicing that indicates the similarity to those of p73 and p63 as identified previously by Daniel Caput and co-workers (29). In the p53 isoforms scheme proposed by Bourdon et al. (22), the SK-N-AS cell line that elicits p53i9 protein expression is consistent with the p53beta isoform. Genomic analysis reveals that the only occurrence of the p53beta isoform in SK-N-AS results from a deletion spanning the intron 9/exon 10 junction. Similar to the p53beta isoform in SK-N-AS, the p53 in IGR-NB8 that lacks 67 amino acids at C-terminus was, alone, unable to induce p21/WAF1 promoter activation except with endogenous wt-p53 on SH-SY5Y cells where transfection with IGR-NB8 significantly augmented the transcriptional activation of the p21/Waf-1 promoter (Figure 5A). Studies by other authors have reported the interaction between the C-terminal domain and another region that impedes the active conformation of p53, suggesting an allosteric model for p53 activity regulation (30). Such events have been demonstrated for the 342-stop mutant, generated by mutagenesis, which can modulate transactivation, growth and apoptosis (31). Moreover, Harms and Chen (32) reported that the C-terminal basic domain inhibits induction of the proapoptotic target gene insulin-like growth factor binding protein 3, suggesting that IGR-NB8 might induce this gene. IGR-N-91 had an abnormally high molecular weight protein due to the duplication of wild-type exons 7-8-9, thus affecting the DBD and OD; and LAN-1, with a mutation at codon 182 (Cys-->stop) concurred with an earlier report showing extremely low levels of mRNA and undetectable protein expression (9).
###end p 50
###begin p 51
###xml 248 256 242 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 294 302 288 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 354 359 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 362 364 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 448 456 442 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21/WAF1</italic>
###xml 579 586 561 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
Notably, all the p53 variants, including SK-N-AS (beta isoform) and IGR-NB8 (C-terminal truncated p53), elicited a total lack of p21 promoter activation. In particular, the p53beta isoform was unable to induce endogenous p21 expression in SK-N-AS (Figure 6), concurring with data obtained from in vitro transfection experiments in H1299 cells by Bourdon et al. (22). For the IGR-N-91 cells, although p53 was mutated and unable to transactivate the p21/WAF1 promoter, the FASAY global test was not conclusive since approximately80% of colonies were white and nearly 20% (see also Table 2), though not enough, were red. Moreover, in this particular line, standard sequencing on cDNA using primers located within each exon as used for routine tumor analysis was unable to detect any anomalies in p53 genetic status (data not shown). These results enlighten the limit of the conventional tests to detect a transcription inactivation of p53 brought by duplication within the DBD.
###end p 51
###begin p 52
###xml 12 15 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 117 120 117 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 581 584 581 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
Analysis of p53 genomic status was explored by FISH experiments, in search for a potential biallelic inactivation of p53, with a mutation of one allele and a deletion of the second one. This situation was indeed clearly observed in IGR-N-91 and SK-N-AS cell lines, with an unambiguous loss of one chromosome 17p arm in all cells of both. SK-N-BE(2), LAN-1 and IGR-NB-8 cell lines showed a more complex genomic situation which should be relevant of variable copy numbers of chromosome 17 bearing in most cases (LAN-1) or in all cases [SKN-BE(2), IGR-NB8] the mutated characteristic p53 allele. Our data therefore clearly demonstrate that each technique has a role and a combination of techniques is required in order to correctly define the p53 phenotype and genotype in tumor and particularly in NB cells.
###end p 52
###begin p 53
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
Our data enlighten a high frequency of the C-terminal abnormalities (3/5 mutated) in NB cell lines. For SK-N-AS and IGR-NB8, a part of the oligomerization domain was lost and IGR-N-91 gained an extra oligomerization domain. According to FASAY assay the p53 expressed in IGR-N-91 still specifically bind DNA but not the p53 expressed in SK-N-AS and IGR-NB8 in agreement with previous published data obtained by electrophoretic mobility shift assay (33).
###end p 53
###begin p 54
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
With regards to biological relevance, different mutants within the DBD vary in their oncogenicity. They are classified into two types depending of the location of the mutation, mutations of class I occur in the DNA contact areas, while class II mutations occur in areas important for the conformational stability of p53 protein (30). Although both class I and class II mutants have loss its ability to specifically bind DNA, class II mutations have been shown to be more oncogenic than class I. However, to our knowledge the oncogenicity of mutant affecting the C-terminal domain have not been studied. The biological role of the C-terminal mutants needs now to be thoroughly investigated in NB tumors.
###end p 54
###begin p 55
We are very grateful to Prof. Gilles Vassal for supplying the IGR-NB8 cell line, Dr Michel Barrois for assistance with the design of primers for TaqMan, and Dr Marc Lipinski and Dr David Cappellen for valuable discussions. Edited by English Booster. D.G. is supported by a 'Ligue contre le Cancer' fellowship. This work was partially supported by grants from the 'Ligue contre le Cancer, Comite du Cher' and 'Association pour la Recherche sur le Cancer'. Funding to pay the Open Access publication charges for this article was provided by the Association pour la Recherche sur le Cancer, Villjuif, France.
###end p 55
###begin p 56
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement.</italic>
Conflict of interest statement. None declared.
###end p 56
###begin title 57
REFERENCES
###end title 57
###begin article-title 58
###xml 8 13 <span type="species:ncbi:9606">human</span>
p53 and human cancer: the first ten thousand mutations
###end article-title 58
###begin article-title 59
###xml 25 30 <span type="species:ncbi:9606">human</span>
Assessing TP53 status in human tumours to evaluate clinical outcome
###end article-title 59
###begin article-title 60
The UMD-p53 database: new mutations and analysis tools
###end article-title 60
###begin article-title 61
###xml 46 51 <span type="species:ncbi:9606">human</span>
Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations
###end article-title 61
###begin article-title 62
Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors
###end article-title 62
###begin article-title 63
Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide
###end article-title 63
###begin article-title 64
Parc: a cytoplasmic anchor for p53
###end article-title 64
###begin article-title 65
Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life
###end article-title 65
###begin article-title 66
###xml 21 26 <span type="species:ncbi:9606">human</span>
Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines
###end article-title 66
###begin article-title 67
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line
###end article-title 67
###begin article-title 68
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines'
###end article-title 68
###begin article-title 69
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse
###end article-title 69
###begin article-title 70
Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line
###end article-title 70
###begin article-title 71
Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts
###end article-title 71
###begin article-title 72
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human tumour suppressor gene p53 is alternatively spliced in normal cells
###end article-title 72
###begin article-title 73
Accumulation of an inactive form of p53 protein in cells treated with TNF alpha
###end article-title 73
###begin article-title 74
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis
###end article-title 74
###begin article-title 75
###xml 107 112 <span type="species:ncbi:9606">human</span>
###xml 117 123 <span type="species:ncbi:10090">murine</span>
A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes
###end article-title 75
###begin article-title 76
Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas
###end article-title 76
###begin article-title 77
Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract
###end article-title 77
###begin article-title 78
The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells
###end article-title 78
###begin article-title 79
p53 isoforms can regulate p53 transcriptional activity
###end article-title 79
###begin article-title 80
A simple p53 functional assay for screening cell lines, blood, and tumors
###end article-title 80
###begin article-title 81
Transcriptional repression by the C-terminal domain of p53
###end article-title 81
###begin article-title 82
Detecting single DNA copy number variations in complex genomes using one nanogram of starting DNA and BAC-array CGH
###end article-title 82
###begin article-title 83
Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome
###end article-title 83
###begin article-title 84
Absence of p53 gene mutations in primary neuroblastomas
###end article-title 84
###begin article-title 85
Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy
###end article-title 85
###begin article-title 86
###xml 110 115 <span type="species:ncbi:9606">human</span>
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
###end article-title 86
###begin article-title 87
Twenty years of p53 research: structural and functional aspects of the p53 protein
###end article-title 87
###begin article-title 88
COOH-terminal domain of p53 modulates p53-mediated transcriptional transactivation, cell growth, and apoptosis
###end article-title 88
###begin article-title 89
The C terminus of p53 family proteins is a cell fate determinant
###end article-title 89
###begin article-title 90
Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53
###end article-title 90
###begin title 91
Figures and Tables
###end title 91
###begin p 92
###xml 55 56 55 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 169 170 166 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 200 207 197 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
p53 expression of different neuroblastoma cell lines. (A) Western blot from protein total extracts (upper panel); beta-actin was used as loading control (lower panel). (B) RT-PCR using F1-R7 primers (Table 1); amplified fragment was normalized by GAPDH.
###end p 92
###begin p 93
###xml 92 93 92 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 210 217 210 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 514 515 514 515 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 582 589 582 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
Detection of p53 mRNA abnormalities in SK-N-AS (AS) in comparison with SH-SY5Y (SH) cells. (A) Amplification of p53 cDNA using primers from exons 8 to 10 as indicated below each arrow; for precise position see Table 1 and GenBank K03199: F2 (forward primer in exon 8); R3 (reverse primer at the junction of exon 8/9); R4 (the first moiety of exon 9); R5 (exon 9, 30 nt downstream R4); R6 (beginning of exon 10). Note that no amplification was observed in SK-N-AS from exon 10 (last lane), in contrast to SH-SY5Y. (B) RT-PCR from SK-N-AS compared to SH-SY5Y cells. Specific primers (Table 1) were used to amplify the DBD, the p53beta isoform (beta) and the C-terminal domain (C-ter).
###end p 93
###begin p 94
###xml 89 90 89 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 199 200 199 200 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 336 343 336 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
Identification of a deletion spanning the intron9/exon 10 junction of SK-N-AS p53 gene. (A) Schematic representation of p53 gene from intron 7 to intron 10 with the position of amplified fragments; (B) PCR fragments amplified from SH-SY5Y (SH) and SK-N-AS (AS) DNA with the primer pairs a, b, c and d. The primer sequences are given in Table 1; contl: PCR performed in parallel without DNA.
###end p 94
###begin p 95
###xml 62 63 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 550 551 550 551 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 774 781 774 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 34 39 <span type="species:ncbi:4932">yeast</span>
###xml 131 136 <span type="species:ncbi:4932">yeast</span>
###xml 414 419 <span type="species:ncbi:4932">yeast</span>
###xml 568 573 <span type="species:ncbi:4932">yeast</span>
p53 transactivation ability using yeast-based assay (FASAY). (A) Schematic representation of the analysis of p53 mutants using the yeast homologous recombination expression vector pRDI-22 carrying the 5' and 3' ends of the p53 open reading frame and the split forms, pFW35 and pFW34 (lacking p53 fragment from amino acids 66 to 210 for split 5' and 211-348 for split 3', respectively) transfected into YPH500 Ade2 yeast strain. This strain repairs double-strand breaks in transfected plasmids by homologous recombination as 'gap repair' (see text). (B) Photographs of yeast colonies showing 100% wild-type p53 where all colonies are white (a), or special mutated p53 by duplication of exons 7-9 found in IGR-N-91 cells (b), where white and red colonies were mixed (see also Table 2), and mutated p53 such as those in SK-N-BE(2), where all colonies are red (c).
###end p 95
###begin p 96
###xml 72 73 72 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 84 85 84 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 251 259 250 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21/WAF1</italic>
###xml 245 250 <span type="species:ncbi:9606">human</span>
p53 transactivation ability by luciferase test using plasmid pE1B-hWAF1(A) and Bax (B). p53-deficient LAN-1 cells (p53-) (left panel) or SH-SY5Y (p53+) (right panel) were cotransfected with 0.5 mug of the luciferase reporter gene containing the human p21/WAF1-p53-responsive element and with 1 mug of the expressing vector as indicated. Cells were collected and subject to luciferase assay, 24 h following cotransfection. The values represent mean relative luciferase activity from three independent experiments. SH-SY5Y, IGR-N-91, SK-N-BE(2), SK-N-AS and IGR-NB8 were termed as SH, N91, BE(2), AS and NB8, respectively.
###end p 96
###begin p 97
###xml 547 555 535 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 731 733 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
Western blot showing induction of p21/WAF1 protein by plasmid-recombinant expression vector of p53 variant transfected into p53-negative LAN-1 cells. LAN-1 cells were seeded onto 6-well plates. At a density of approximately60%, confluence cells were transfected with recombinant vector using Lipofectamine 2000 reagent according to the supplier's instructions (Invitrogen). To ascertain the transfection efficiency, cells were transfected in parallel experiments with pEGFP-C1 vector (Promega). The empty vector was used as a control. As shown in Figure 1, note that the p53 protein from the IGR-N-91 cells analyzed by SDS-PAGE migrated more slowly than the wild-type p53 due to duplication of exons 7-8-9 as described previously (13).
###end p 97
###begin p 98
Western blot showing induction of endogenous p21/WAF1 in different neuroblastoma cell lines in response to 10 muM cisplatin treatment. Protein p21/WAF1 induction was observed only in the three wild-type p53 NB cell lines and the protein was differentially accumulated.
###end p 98
###begin p 99
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
Visualization of chromosome 17 copy number and p53 genes by FISH experiments. Chromosome 17 centromere probe is green labeled and TP53 gene probe red labeled. Only the predominant clone of each cell line is presented and its frequency indicated.
###end p 99
###begin p 100
###xml 207 210 207 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 348 349 348 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
Structure of p53 proteins in different neuroblastoma cell lines. The three functional domains are represented: TAD, transactivation domain; DBD, DNA-binding domain; OD, oligomerization domain. The wild-type p53 gene in SH-SY5Y, IMR-32 and LAN-5 cells contains 11 exons that encode 393 amino acids. In SK-N-BE(2) cells, p53 is mutated at codon 135 (*), which converts cysteine to phenylalanine. In IGR-N-91 cells, a duplication of exons 7-8-9 adds an additional 107 amino acids leading to a total of 500. In SK-N-AS cells, a mutation due to alternate splicing downstream of exon 9 leads to a protein of 341 amino acids whereas in IGR-NB8 cells, the p53 protein ends at 326 amino acids owing to the mutation E326STOP.
###end p 100
###begin p 101
Primers pairs for RT-PCR of the p53 (mRNA and gene)
###end p 101
###begin p 102
According to GenBank sequence accession no. *KO3199 (mRNA) and **X54156 (HSP53G); F, forward sequence; R, reverse sequence.
###end p 102
###begin p 103
Functional activity of p53 from NB cells using FASAY assays
###end p 103
###begin p 104
Mean value from three independent experiments (*+/-6%, **+/-3%); ***wt and mut phenotypes: red and white colonies </=10%, respectively; wt, wild-type; mut, mutant.
###end p 104
###begin p 105
Genomic status of chromosome 17 centromere and TP53 gene explored by FISH
###end p 105

